Clinical Trials Browser

Phase 1 × nilotinib × 90 days × Clear all

NCT02379416 2026-04-21

Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors

Phase 1 Completed

Neoplasms